Leading the FDA has long been one of the greatest professional achievements in American health. At the start of every administration, doctors jockey for the role, hoping to steer an agency that regulates 20 cents of every dollar spent in the United States. To be the FDA commissioner who presides over the approval of a cure for a previously intractable disease, or who launches an investigation into a product that is sickening Americans, is to etch your name into the annals of modern medicine.

This article contains spoilers through the seventh episode of Severance, Season 2.
The promise of Severance is a seductive one: The titular procedure separates a person’s work self from the rest of their identity, granting them a literal work-life balance. Lumon, the biotech company that offers severance—which involves implanting a microchip into employees’ brains—markets it as a method to free oneself of difficult feelings or experiences.

Long live the king!
Down with the king!
President Donald Trump sees the appeal of both.
Trump jokingly declared himself a sovereign last month, while his advisers distributed AI-generated photos of him wearing a crown and an ermine robe to celebrate his order to end congestion pricing in New York City. “He who saves his Country does not violate any Law,” he’d decreed a few days earlier, using a phrase sometimes attributed to Napoleon Bonaparte, the emperor of the French.

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.
Yesterday marked four months since Election Day, but North Carolinians somehow still don’t know who will fill a key seat on the state supreme court.
The problem is not that no one knows who won. Justice Allison Riggs, an incumbent Democrat, won by a tiny margin—just 734 votes out of 5,723,987.

Right around the time that Donald Trump was arriving at the U.S. Capitol to address a joint session of Congress—the longest such speech, it would turn out, in the history of the presidency—Elissa Slotkin, the newly elected Michigan senator tasked with delivering the Democratic Party’s rebuttal, was telling me all the things she wouldn’t be talking about.

The key to understanding this morning’s Supreme Court ruling unfreezing American foreign aid is that two different rulings are at issue here, and teasing apart those technicalities reveals a loss that is perhaps more significant for the Trump administration than is first apparent.
The two orders both come from U.S. District Court Judge Amir Ali.